The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Human cecal bile acids: concentration and spectrum
Abstract
To obtain information on the concentration and spectrum of bile acids in human cecal content, samples were obtained from 19 persons who had died an unnatural death from causes such as trauma, homicide, suicide, or drug overdose. Bile acid concentration was measured via an enzymatic assay for 3α-hydroxy bile acids; bile acid classes were determined by electrospray ionization mass spectrometry and individual bile acids by gas chromatography mass spectrometry and liquid chromatography mass spectrometry. The 3α-hydroxy bile acid concentration (μmol bile acid/ml cecal content) was 0.4 ± 0.2 mM (mean ± SD); the total 3-hydroxy bile acid concentration was 0.6 ± 0.3 mM. The aqueous concentration of bile acids (supernatant after centrifugation) was identical, indicating that most bile acids were in solution. By liquid chromatography mass spectrometry, bile acids were mostly in unconjugated form (90 ± 9%, mean ± SD); sulfated, nonamidated bile acids were 7 ± 5%, and nonsulfated amidated bile acids (glycine or taurine conjugates) were 3 ± 7%. By gas chromatography mass spectrometry, 10 bile acids were identified: deoxycholic (34 ± 16%), lithocholic (26 ± 10%), and ursodeoxycholic (6 ± 9), as well as their primary bile acid precursors cholic (6 ± 9%) and chenodeoxycholic acid (7 ± 8%). In addition, 3β-hydroxy derivatives of some or all of these bile acids were present and averaged 27 ± 18% of total bile acids, indicating that 3β-hydroxy bile acids are normal constituents of cecal content. In the human cecum, deconjugation and dehydroxylation of bile acids are nearly complete, resulting in most bile acids being in unconjugated form at submicellar and subsecretory concentrations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This study also concluded that SCFA receptors, including Gpr43 and Olfr78, were not readily detectable in the cardiac transcriptome.”
From Dietary metabolism, the gut microbiome, and heart failure (2019) · cites this paper as [124]
In the citing paper
“Moreover, acetate-producing bacteria have also recently been identified in preclinical studies as a potential protective intervention for the treatment of hypertension, adverse cardiac hypertrophy, and fibrosis development124.”
From Dietary metabolism, the gut microbiome, and heart failure (2019) · cites this paper as [124]
Citations
Cites
Physiology of the Gastrointestinal Tract
Johnson, L. R. (2006) · Elsevier eBooks · doi:10.1016/b978-0-12-088394-3.x5000-4 · Cited by 4,616
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829
Measurement of gastrointestinal pH profiles in normal ambulant human subjects
Evans, D. F., Pye, G., Bramley, R., Clark, A. G., Dyson, T. J., & Hardcastle, J. D. (1988) · Gut · doi:10.1136/gut.29.8.1035 · Cited by 1,240
Meier, P. J., & Stieger, B. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.082201.100300 · Cited by 594
Colonic Secretion of Water and Electrolytes Induced by Bile Acids: Perfusion Studies in Man
Mekhjian, H. S., Phillips, S. F., & Hofmann, A. F. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106644 · Cited by 584
Self-citationHofmann, A. F., & Poley, J. R. (1972) · Gastroenterology · doi:10.1016/s0016-5085(72)80109-4 · Cited by 549
Self-citationHofmann, A. F., & Poley, J. R. (1972) · PubMed · Cited by 477
Self-citationHofmann, A. (1963) · Biochemical Journal · doi:10.1042/bj0890057 · Cited by 353
Self-citationRossi, S. S., Converse, J. L., & Hofmann, A. F. (1987) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38684-3 · Cited by 316
Self-citationSchiff, E. R., Small, N. C., & Dietschy, J. M. (1972) · Journal of Clinical Investigation · doi:10.1172/jci106931 · Cited by 303
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–262 of 262
Zhang, N., Zheng, W., Bakker, W., van Ravenzwaay, B., & Rietjens, I. M. C. M. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110445 · Cited by 7
González, P. M., Lagos, C. F., Ward, W. C., & Polli, J. E. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400575t · Cited by 7
Avcioglu, S. Y., & Berkel, Ç. (2025) · Apmis · doi:10.1111/apm.70066 · Cited by 6
Wu, W., Wang, S., Xue, C., & Dong, N. (2026) · Animal nutrition · doi:10.1016/j.aninu.2025.10.004 · Cited by 6
Rodríguez-Rodríguez, E. R., Nordvang, R. T., Petersson, M., Rendsvig, J. K. H., Arendrup, E. W., Fernández‐Quintero, M. L., Jenkins, T. P., Laustsen, A. H., & Thrane, S. W. (2024) · Protein Science · doi:10.1002/pro.5035 · Cited by 6
Redesign of ultrasensitive and robust RecA gene circuit to sense DNA damage
Chen, J. X., Lim, B., Steel, H., Song, Y., Ji, M., & Huang, W. E. (2021) · Microbial Biotechnology · doi:10.1111/1751-7915.13767 · Cited by 7
Untargeted analysis of the serum metabolome in cats with exocrine pancreatic insufficiency
Barko, P. C., & Williams, D. A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0257856 · Cited by 6
Glowacki, R. W. P., Engelhart, M. J., Till, J. M., Kadam, A., Nemet, I., Sangwan, N., & Ahern, P. P. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.03419-24 · Cited by 5
Bile acids as gatekeepers: Orchestrating gut-liver axis for metabolic and immune balance
Chen, Q., Xin, L. I. U., & Jiang, Z.-H. (2026) · Hepatobiliary & pancreatic diseases international · doi:10.1016/j.hbpd.2026.01.001 · Cited by 6
Liu, J., Elsheikha, H. M., Lei, C.-C., Qin, S., Liu, Y., Ni, H.-B., Qin, Y., Yu, H.-L., Su, J.-W., Chen, B.-N., et al. (2026) · BMC Microbiology · doi:10.1186/s12866-026-04750-0 · Cited by 5
Beebe, M. A., Paredes‐Sabja, D., Kociolek, L. K., Rodríguez, C., & Sorg, J. A. (2025) · Applied and Environmental Microbiology · doi:10.1128/aem.00964-25 · Cited by 5
Schüler, M. A., Daniel, R., & Poehlein, A. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1374708 · Cited by 5
Personalized nutrition for colorectal cancer
Wang, K., & Song, M. (2021) · Advances in cancer research · doi:10.1016/bs.acr.2021.02.004 · Cited by 5
Gut microbial pathways for bile acid metabolism
Frost, F., & Lerch, M. M. (2021) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn-21-11 · Cited by 4
Takahashi, K., Kuwahara, Y., Kato, I., Asano, S., Kozakai, T., Marunaka, Y., & Kuwahara, A. (2022) · Biomedical Research · doi:10.2220/biomedres.43.223 · Cited by 4
Structure-guided design of a synthetic bile acid that inhibits Clostridioides difficile TcdB toxin
Miletic, S., Icho, S., Li, Z., Tam, J., Rose, E. C., Perkins, C. E., Nakhi, A., Yang, X., Hang, H. C., Rubinstein, J. L., et al. (2025) · Nature Microbiology · doi:10.1038/s41564-025-02179-1 · Cited by 5
The effects of photoactivated ciprofloxacin and bile acids on biofilms on bile duct catheters
Eberhardt, N., González-Santamarina, B., Enghardt, M.-L., Rohland, O., Hussain, I., Tannert, A., Thieme, L., Rubio, I., Rödel, J., Löffler, B., et al. (2024) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2024.107086 · Cited by 4
Transformation of chenodeoxycholic acid by thermophilic Geobacillus stearothermophilus
Afzal, M., Oommen, S., & Al‐Awadi, S. (2011) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.34 · Cited by 4
Huang, Y. Y., Price, M. N., Hung, A., Gal-Oz, O., Ho, D., Carion, H., Deutschbauer, A. M., & Arkin, A. P. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.10.10.511384 · Cited by 4
Perry, E. K., Udayasuryan, B., Zegeye, E. K., Rose, C. M., Reichelt, M., & Tan, M. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00854-z · Cited by 3
Bile Acids: A Bridge Linking Gut Microbiota and NAFLD
Zhang, J., Wang, C., Ji, X., Wu, F., Lin, Z., Zhou, Y., Xu, C., & Wang, F. (2022) · Advanced Gut & Microbiome Research · doi:10.1155/2022/4752148 · Cited by 3
Cultivation of Spore-Forming Gut Microbes Using a Combination of Bile Acids and Amino Acids
Onizuka, S., Tanaka, M., Mishima, R., & Nakayama, J. (2021) · Microorganisms · doi:10.3390/microorganisms9081651 · Cited by 3
Microbial adaptation and host signaling: Bacteroides–bile acid interactions in gut health
Silva, C. M. G., Ferreira, R. B. R., & Lobo, L. A. (2026) · Anaerobe · doi:10.1016/j.anaerobe.2026.103041 · Cited by 2
A Screening Assay for Bile Acid-Transforming Microorganisms Using Engineered Bacterial Biosensors
Dallera, D., Pastorelli, D., Bellato, M., Chiacchiera, A. F., Usai, F., Angelis, M. G. C. D., Brun, P., Magni, P., & Pasotti, L. (2025) · Biosensors · doi:10.3390/bios15110716 · Cited by 2
The influence and mechanism of gut microbiota on spermatogenesis
Zhou, X., Ge, Z., Yang, X., Liu, Y., Li, Y., Chen, L., Lv, L., & Chen, G. D. (2026) · Cell Biology and Toxicology · doi:10.1007/s10565-026-10168-1 · Cited by 2
Vancomycin eliminates gut deoxycholic acid, restoring ER proteostasis in ILC2s and relieving colitis
Tian, Q., Liu, H., Gu, X., Shen, J., Yuan, X., Zheng, M., Zhai, Y., Chen, Y., Han, P., Ma, Y., et al. (2026) · JCI Insight · doi:10.1172/jci.insight.197470 · Cited by 2
Peesapati, S., & Roy, D. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2137242 · Cited by 2
Tanaka, M., & Nakayama, J. (2022) · KAGAKU TO SEIBUTSU · doi:10.1271/kagakutoseibutsu.60.79 · Cited by 1
Bile Acids Are Potential Negative Allosteric Modulators of M1 Muscarinic Receptors
Yu, W., MacKerell, A. D., Weber, D. J., & Raufman, J. (2025) · Biomolecules · doi:10.3390/biom15091326 · Cited by 1
Self-citationMetabolites as potential tools for the diagnosis and treatment of saccular intracranial aneurysms
Ren, X., Wang, Z., Xiang, Y., Fu, Y., Xue, J., & Zheng, L. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118567 · Cited by 1
Liu, X., Wu, R., Wang, N. N., Xu, H. J., Rong, X., Li, C., & Cao, M. (2025) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2025.105534 · Cited by 1
Reghu, G., Fathima, A., Swaminathan, N., Sakhuja, R., & Jamma, T. (2026) · Steroids · doi:10.1016/j.steroids.2026.109749 · Cited by 1
The Cross Talk Between Bile Acids and Intestinal Microbiota
Fiamoncini, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815249-2.00014-2 · Cited by 1
Setchell, K. D. R., & Kohli, R. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-37591-7.00002-1 · Cited by 1
Dror, Y., Rimon, E., & Vaida, R. (2020) · Springer eBooks · doi:10.1007/978-3-030-39823-1_14 · Cited by 1
Zeng, H., Safratowich, B. D., Cheng, W., & Briske‐Anderson, M. (2025) · Nutrients · doi:10.3390/nu17061072 · Cited by 2
Luengo, J. M., & Olivera, E. R. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7183-1_8 · Cited by 1
Bile Acid Induced Diarrhoea Pathophysiological and Clinical Aspects
Bajor, A. (2008) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 1
Hussein, M. H. (2018) · LSHTM Research Online (London School of Hygiene and Tropical Medicine) · doi:10.17037/pubs.04647857 · Cited by 1
Schaffner, S. H., Lee, A. V., Pham, M. T. N., Kassaye, B. B., Li, H., Tallada, S., Lis, C., Lang, M., Liu, Y., Ahmed, N., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.21.392837 · Cited by 1
Introduction: Utility of Mathematical Models in Drug Development and Delivery
Gordi, T., & Berner, B. (2021) · Wiley eBooks · doi:10.1002/9781119772767.ch1 · Cited by 1
Investigation of the pathomechanism of diarrhoea-related diseases
Pallagi, É. (2015) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.2710
Investigating enteroaggregative Escherichia coli virulence factors in human intestinal infection
Ellis, S. (2018) · UEA Digital Repository (University of East Anglia)
Mythen, S. M. (2018) · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
Pieper, D. H. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.738152737.793581741
Stieger, B. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.738152737.793576090
Microbiota and other detrimental metabolites in colorectal cancer
González, A., Fullaondo, A., Odriozola, I., & Odriozola, A. (2024) · Advances in genetics · doi:10.1016/bs.adgen.2024.08.006
Gut Microbiome Modulation of Innate Immunity in Neurodegenerative Diseases
Merchak, A. R., Menees, K. B., Bolen, M. L., & Tansey, M. G. (2024) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190931544.013.14
Lin, Z., Zeng, H., Chen, T., & Li, Z. (2025) · Theoretical and Natural Science · doi:10.54254/2753-8818/2024.19377
Firrman, J., Linshu, L. I. U., Mahalak, K. K., Lemons, J. M. S., Narrowe, A. B., Friedman, E. S., Wu, G. D., & de Weile, T. V. (2026) · mSystems · doi:10.1128/msystems.01373-25 · Cited by 1
Influence of bile acids metabolism on hepatic immunity in mice
Guinot, V. (2022) · theses.fr (ABES) · doi:10.70675/b69bb11eza30fz4874z9af2za6e31b2d5ad8
Stocchero, M., Pirillo, P., Poloniato, G., Naturale, M., Cananzi, M., & Giordano, G. (2026) · Analytical Chemistry · doi:10.1021/acs.analchem.5c07304
Lactic acid bacteria from Amazonian fruits: Isolation and evaluation of probiotic potential
Pillaca‐Pullo, O. S., Ortiz‐Saravia, A. M., Mendoza‐Quezada, M., Lopes, A. M., Huaman‐Susanibar, A. I., Villacrés-Vallejo, J., & Cruz, N. B. (2026) · Journal of Chemical Technology & Biotechnology · doi:10.1002/jctb.70216
Yanagawa, Y., Yoshida, N., Makiuchi, T., Kawashima, A., Uemura, H., Aoki, T., Mizushima, D., Gatanaga, H., & Watanabe, K. (2026) · Gut Pathogens · doi:10.1186/s13099-026-00845-1
An engineered Clostridial mini consortium modulates intestinal inflammationPreprint
Ionescu, E., Arnold, J. H., Weber, C. R., Mimee, M., & Nagler‐Anderson, C. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.11.743107
Redesigning Probiotic Bile Tolerance Assays: A Physiologically Representative Model
Guo, C. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6c06446
Zeng, L., Xue, B., Ren, X., 宫树桐, & Yan, J. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1781229
Bile acids as mediators of microbiota signaling in entero-hepatic disorders
Fiorucci, S., Marchianò, S., Giorgio, C. D., Urbani, G., Monti, M. C., Zampella, A., Distrutti, E., & Biagioli, M. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118341
Pleiotropic roles of microbial bile acid metabolism in intestinal health and diseases
Qi, M., Liu, X., & Gonzalez, F. J. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2026.09.010
Schnizlein, M. K., 홍봉진, Nguyen, J. T., Jones, K. A., Rodriguez, A. I., Fiebig, A., Campagna, S. R., Balunas, M. J., O’Halloran, T. V., & Crosson, S. (2026) · mSystems · doi:10.1128/msystems.00749-26 · Cited by 1
Metadata
- Authors
- Hamilton, J. P., Xie, G., Raufman, J.-P., Hogan, S., Griffin, T. L., Packard, C. A., Chatfield, D. A., Hagey, L. R., Steinbach, J. H., & Hofmann, A. F.
- Affiliations
- University of Maryland, Baltimore (US)
- Maryland Department of Agriculture (US)
- San Diego State University (US)
- University of California San Diego (US)
- Venue
- American Journal of Physiology-Gastrointestinal and Liver Physiology
- Publisher
- American Physiological Society
- Published
- 2007-07
- Volume
- 293
- Issue
- 1
- Pages
- G256-G263
- ISSN
- 0193-1857 (ISSN-L)
- 1522-1547
- OpenAlex
- W2124723056
- Cited by
- 263
- References
- 53
- Citations by year
- 2026: 19 · 2025: 17 · 2024: 23 · 2023: 14 · 2022: 24 · 2021: 27 · 2020: 21 · 2019: 17 · 2018: 18 · 2017: 6 · 2016: 7 · 2015: 6 · 2014: 6 · 2013: 8 · 2012: 12
- FWCI
- 16.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Physiology-Gastrointestinal and Liver Physiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (CA107345, R01CA107345)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK64891, T32DK067872, R03DK064891)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Physical Sciences › Chemistry › Analytical Chemistry › Analytical Chemistry and Chromatography
- Keywords
- bile acids, cecal contents, bile acid concentration, bile acid conjugation, deoxycholic acid, lithocholic acid, ursodeoxycholic acid, cholic acid, chenodeoxycholic acid, bile acid deconjugation
- MeSH terms
- Bile Acids and Salts, Cecum, Chenodeoxycholic Acid, Cholic Acids, Chromatography, Liquid, Deoxycholic Acid, Gastrointestinal Contents, Humans, Lithocholic Acid, Gas Chromatography-Mass Spectrometry, Ursodeoxycholic Acid, Spectrometry, Mass, Electrospray Ionization, Tandem Mass Spectrometry
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
